SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRoebuck Food Regulatory News (RFG)

Share Price Information for Roebuck Food (RFG)

Share Price is delayed by 15 minutes
Get Live Data
26.50    0.00 (0.00%)
Bid:
26.00
Ask:
27.00
Spread: 1.00 (3.846%)
Market Cap: £26.80m
RFG Live PriceLast checked at - London Stock Exchange

Intraday Roebuck Food Share Chart

Change in Director Responsibilities

18 Feb 2022 13:39

RNS Number : 1736C
Roebuck Food Group PLC
18 February 2022
Β 

The information contained within this announcement was previously deemed by the Company to constitute inside information as stipulated by Market Abuse Regulation (EU) No 596/2014 ("EU MAR") and the retained UK law version of EU MAR pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2019 (SI 2019/310) ("UK MAR"). With the publication of this announcement via a Regulatory Information Service, this information is now considered to be in the public domain

Β 

Roebuck Food Group plc ("Roebuck" or the "Company")

Settlement of Completion Accounts on Cold Store Disposal

Change in Director Responsibilities

18 February 2022

On 30 September 2021, Roebuck Food Group plc (then named Norish plc) announced the conditional agreement for the sale of its cold storage division to Nichirei Holding Holland B.V. ("the Purchaser"), a wholly-owned subsidiary of Nichirei Logistics Group Inc. for a consideration of Β£65.706 million ("the Disposal"). Following the settlement of indebtedness and the operation of a completion accounts mechanism in the Sale and Purchase Agreement, it was then anticipated that it would result in a consideration receivable by the Company of approximately Β£57.3 million.Β The completion of the Disposal was announced on 29 October 2021.

Following Completion, the Company engaged with the Purchaser on the completion accounts exercise. In the course of that exercise, a difference arose in relation to the amount of a provision for capital expenditure in respect of works to certain of the cold store division's premises, following the receipt of tenders and indicative pricing for these works. Following a due diligence exercise, the Company has ultimately agreed that an adjustment to the purchase price of Β£1,160,765 be made, with a consequent payment of an equivalent amount to the Purchaser.Β 

Commenting on the matter, Executive Chairman Ted O'Neill stated: "while it is obviously disappointing that our original estimate of capital expenditure could not be borne out, I am pleased that we have settled the matter at this early stage and without engaging in what might have been a protracted and lengthy exercise.Β The company is able to pay this amount from its existing cash resources without any recourse to borrowing or any effect to its ongoing business plans."

The Company also announces that it has been agreed with Deputy Chairman Aidan Hughes that he should continue in an executive role until 31 December 2022, with primary responsibility for corporate transactions and new ventures, on the same terms and conditions as applied heretofore (save as to responsibilities).

The Directors of the Company accept responsibility for the contents of this announcement.

Β Enquiries:

Roebuck

Β 

Aidan Hughes, Deputy Chairman

Telephone: + 44 1293 862 498

Β 

Β 

Β Davy

Β 

Anthony Farrell

Telephone: + 353 1 679 6363

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCSFWFDAEESEEE
Date   Source Headline
2nd Jun 202611:10 amRNSShareholding Clarification
2nd Jun 20267:00 amRNSChange of Nominated Adviser
28th May 202611:32 amRNSResult of AGM
5th May 20263:35 pmRNSAnnual Report 2025 and Notice of AGM 2026
29th Apr 20262:44 pmRNSPreliminary Results
27th Jan 20267:00 amRNSTrading Update
30th Sep 202512:00 pmRNSInterim Results 2025
30th May 20255:30 pmRNSResult of AGM
2nd May 20259:00 amRNSAnnual Report 2024 and Notice of AGM 2025
28th Mar 20257:00 amRNSPreliminary Results
25th Feb 20252:00 pmRNSAppointment of Non-Executive Director and Chairman
7th Feb 20256:08 pmRNSCompletion of Investment
28th Jan 20255:45 pmRNSHolding(s) in Company
23rd Jan 20253:19 pmRNSResult of Extraordinary General Meeting
2nd Jan 20257:00 amRNSDate of Upcoming EGM
23rd Dec 20242:54 pmRNSPosting of Circular with Notice of EGM
20th Dec 20246:26 pmRNSResult of Placing and Subscription
20th Dec 202412:00 pmRNSProposed co-Investor and Fundraise Update
13th Dec 20246:14 pmRNSProposed Investment and Fundraising
22nd Nov 20247:00 amRNSNotification of substantial shareholding
21st Oct 20243:00 pmRNSChairman Ted O’Neill
27th Sep 20247:00 amRNSInterim Results 2024
6th Sep 20242:15 pmRNSDisposal of Animal Protein Division
29th Aug 20249:45 amRNSResult of Extraordinary General Meeting
9th Aug 20242:50 pmRNSPosting of Circular with Notice of EGM
1st Aug 20247:00 amRNSProposed disposal of Animal Protein Division
5th Jul 20245:10 pmRNSHolding(s) in Company
5th Jul 20245:00 pmRNSHolding(s) in Company
30th May 20243:30 pmRNSResult of AGM
29th May 20245:20 pmRNSDisposal of Dairy Division
14th May 20245:50 pmRNSNotice of AGM
30th Apr 20244:30 pmRNS2023 Annual Report
28th Mar 202410:20 amRNSCHAIRMAN'S STATEMENT - FINAL RESULTS
11th Jan 20244:50 pmRNSContinuance in Office of Director
4th Dec 20236:18 pmRNSIssue of Consideration Shares
30th Nov 20233:04 pmRNSResults of Extraordinary General Meeting
6th Nov 20235:10 pmRNSPlacing and Related Subscription Update
6th Nov 20232:00 pmRNSPosting of Circular with Notice of EGM
3rd Nov 20236:28 pmRNSResult of Placing and related Subscription
3rd Nov 20237:05 amRNSProposed Acquisition and Launch of Placing
29th Sep 20237:00 amRNSInterim results 2023
29th Sep 20237:00 amRNSResult of AGM
29th Aug 20234:28 pmRNSNotice of AGM
5th Jul 20237:00 amRNSManagement and Directorate Changes
28th Apr 20235:30 pmRNS2022 Annual Report
14th Apr 202310:00 amRNSDirectorate Change
31st Mar 20232:13 pmRNSChairman's Statement - Final Results
3rd Mar 20235:45 pmRNSExecutive Director Bonus
30th Dec 20227:00 amRNSDeputy Chairman
17th Nov 20225:00 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.